Filing Flows › Opko Health (OPK) › Product revenue
Opko Health (OPK) Product revenue by quarter
Opko Health's Product revenue was $41.8M in Q3 2026 (third quarter 2026), -3% from Q2 2026. Over the last 7 quarters it ranged from $34.8M (Q1 2025) to $43.7M (Q4 2025).
| Quarter | Product revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $41.8M | -3% | +11% |
| Q2 2026 | $42.9M | +13% | +5% |
| Q1 2026 | $38.0M | -13% | +9% |
| Q4 2025 | $43.7M | +16% | — |
| Q3 2025 | $37.7M | -8% | — |
| Q2 2025 | $40.7M | +17% | — |
| Q1 2025 | $34.8M | — | — |
Q3 2026 at a glance
Opko Health, Q3 2026: revenue $65.4M (+16% year over year), operating margin -48.0%, net loss $53.5M, operating cash flow −$36.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Opko Health's Product revenue?
Opko Health's Product revenue was $41.8M in Q3 2026 (third quarter 2026), -3% from Q2 2026.
How has Opko Health's Product revenue changed?
Over the last 7 quarters it ranged from $34.8M (Q1 2025) to $43.7M (Q4 2025).